Longhorn beetles fauna (Coleoptera: Cerambycidae) of Puszcza Pilicka

On the basis of the material collected from 1981-1995 in Pilica F orest and analysis of published data 76 species of Cerambycidae were recorded. Twenty nine of them have for the first time been recorded from the mentioned area.Zadanie pt. „Digitalizacja i udostępnienie w Cyfrowym Repozytorium Uniwersytetu Łódzkiego kolekcji czasopism naukowych wydawanych przez Uniwersytet Łódzki” nr 885/P-DUN/2014 dofinansowane zostało ze środków MNiSW w ramach działalności upowszechniającej naukę

Pro Libris: Lubuskie Pismo Literacko-Kulturalne, nr 2 (2009)

123 s. : il.

Pro Libris: Lubuskie Pismo Literacko-Kulturalne, nr 4 (2008)

172 s. : il

The microstructure of composite materials in the EN AW-2024 alloy matrix reinforced by α-Al₂O₃ particles

W pracy zostały przedstawione wyniki badań mikrostruktur materiałów kompozytowych wytwarzanych metodą infiltracji ciśnieniowej preform z cząstek ceramicznych α-Al2O3 stopem aluminium EN AW-2024. W badaniach mikroskopowych w szczególności oceniano jakość połączeń na granicach międzyfazowych osnowa-cząstki ceramiczne. Stwierdzono, że krzemionka (SiO2) stosowana do łączenia cząstek tlenku glinu w preformie powoduje wzbogacenie osnowy w krzem (Si), w części dyfundujący do stopu aluminium, który jednak pozostaje w osnowie w postaci skupisk SiO2, szczególnie w obrębie cząstek ceramicznych o dużym stopniu aglomeracji. Infiltracja porów otwartych preformy ceramicznej stopem EN AW-2024 o ograniczonej rzadkopłynności utrudnia proces infiltracji, pozostawiając lokalnie występującą porowatość. Propagacja pęknięć w materiale kompozytowym po badaniach właściwości mechanicznych następuje głównie po granicach międzyfazowych osnowa- -cząstka, szczególnie w miejscach o zwiększonej ilości rezydualnej krzemionki (SiO2) w osnowie. Na powierzchniach przełomów obserwuje się cząstki ceramiczne umocnienia α-Al2O3 o mocnym adhezyjnym połączeniu z osnową, które podczas tworzenia złomu ulegają pęknięciom.The paper presents the results of investigations into the microstructures of composite materials produced by pressure infiltration of preforms of ceramic α-Al2O3 particles with aluminium alloy EN AW-2024. In particular, the quality of the bonds at the interphase boundaries of matrix-ceramic particles was evaluated using microscopy investigations. It was found that silica (SiO2) used for bonding alumina particles in the preform causes an enrichment of the matrix in silicon (Si), which partly diffuses to aluminium alloy, yet remains in the matrix in the form of SiO2 concentrations, especially within ceramic particles with a high degree of agglomeration. The infiltration of open pores of ceramic preforms with EN AW-2024 alloy of limited flowing power hinders the infiltration process, resulting in local porosity. The propagation of cracks in the composite material after tests for mechanical properties occurs mainly along the interphase boundaries of the matrix-particle, especially in places with an increased residual amount of silica (SiO2) in the matrix. On the surfaces of the fractures ceramic particles of the α-Al2O3 reinforcement are observed, they form a strong adhesive bond with the matrix and crack during the formation of scrap metal

Clinical characteristics and treatment outcomes of myeloid sarcoma in children : the experience of the Polish Pediatric Leukemia and Lymphoma Study Group

INTRODUCTION: Myeloid sarcoma (MS) is an extramedullary malignant tumor composed of immature myeloid cells. It occurs in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myeloid leukemia (CML). MS may coincide with disease diagnosis or precede bone marrow involvement by months or even years; it can also represent the extramedullary manifestation of a relapse (1, 2). AIM: The aim of this study is to describe clinical characteristics of children diagnosed with MS in Poland as well as to analyze diagnostic methods, treatment, and outcomes including overall survival (OS), relapse-free survival (RFS), and event-free survival (EFS). The study also attempted to identify factors determining treatment outcomes. PATIENTS: The study group comprised 43 patients (F=18, M=25) aged 0-18 years (median age, 10.0 years; mean age, 8.8 years) diagnosed with MS based on tumor biopsy and immunohistochemistry or identification of underlying bone marrow disease and extramedullary tumor according to imaging findings. METHODS: The clinical data and diagnostic and therapeutic methods used in the study group were analyzed. A statistical analysis of the treatment outcomes was conducted with STATISTICA v. 13 (StatSoft, Inc., Tulsa, OK, USA) and analysis of survival curves was conducted with MedCalc 11.5.1 (MedCalc Software, Ostend, Belgium). Statistical significance was considered at p<0.05. RESULTS: In the study group, MS was most frequently accompanied by AML. The most common site of involvement was skin, followed by orbital region. Skin manifestation of MS was more common in the age group <10 years. The most frequent genetic abnormality was the t(8;21)(q22;q22) translocation. The 5-year OS probability (pOS), 5-year RFS probability (pRFS), and 5-year EFS probability (pEFS) were 0.67 ± 0.08, 0.79 ± 0.07, and 0.65 ± 0.08, respectively. In patients with isolated MS and those with concurrent bone marrow involvement by AML/MDS, pOS values were 0.56 ± 0.12 and 0.84 ± 0.09 (p=0.0251), respectively, and pEFS values were 0.56 ± 0.12 and 0.82 ± 0.08 (p=0.0247), respectively. In patients with and without the t(8;21)(q22;q22) translocation, pEFS values were 0.90 ± 0.09 and 0.51 ± 0.14 (p=0.0490), respectively. CONCLUSIONS: MS is a disease with a highly variable clinical course. Worse treatment outcomes were observed in patients with isolated MS compared to those with concurrent bone marrow involvement by AML/MDS. Patients with the t(8;21)(q22;q22) translocation were found to have significantly higher pEFS. MS location, age group, chemotherapy regimen, surgery, and/or radiotherapy did not have a significant influence on treatment outcomes. Further exploration of prognostic factors in children with MS is indicated